[Federal Register Volume 79, Number 14 (Wednesday, January 22, 2014)]
[Notices]
[Page 3627]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-01156]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Noramco, Inc.

    By Notice dated September 27, 2013, and published in the Federal 
Register on October 25, 2013, 78 FR 64015, Noramco, Inc., 500 Swedes 
Landing Road, Wilmington, Delaware 19801-4417, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as an importer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Phenylacetone (8501).......................  II
Opium, raw (9600)..........................  II
Poppy Straw Concentrate (9670).............  II
Tapentadol (9780)..........................  II
------------------------------------------------------------------------

    The company plans to import the Opium, raw (9600) and Poppy Straw 
Concentrate (9670) to manufacture other controlled substances. The 
company plans to import Tapentadol (9780) in intermediate form for the 
bulk manufacture of Tapentadol (9780) for distribution to its 
customers. The company plans to import Phenylacetone (8501) in bulk for 
the manufacture of a controlled substance.
    Comments and requests for hearings on application to import 
narcotic raw material are not appropriate. 72 FR 3417 (2007)
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Noramco, Inc., to import the basic classes of 
controlled substances is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. DEA has investigated Noramco, Inc., 
to ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 
958(a), and in accordance with 21 CFR 1301.34, the above named company 
is granted registration as an importer of the basic classes of 
controlled substances listed.

     Dated: January 14, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2014-01156 Filed 1-21-14; 8:45 am]
BILLING CODE 4410-09-P